Literature DB >> 19348786

The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144.

Yves Briers1, Mathias Schmelcher, Martin J Loessner, Jelle Hendrix, Yves Engelborghs, Guido Volckaert, Rob Lavigne.   

Abstract

The binding affinity of the N-terminal peptidoglycan binding domain of endolysin KZ144 (PBD(KZ)), originating from Pseudomonas aeruginosa bacteriophage varphiKZ, has been examined using a fusion protein of PBD(KZ) and green fluorescent protein (PBD(KZ)-GFP). A fluorescence recovery after photobleaching analysis of bound PBD(KZ)-GFP molecules showed less than 10% fluorescence recovery in the bleached area within 15 min. Surface plasmon resonance analysis confirmed this apparent high binding affinity revealing an equilibrium affinity constant of 2.95 x 10(7)M(-1) for the PBD(KZ)-peptidoglycan interaction. This unique domain, which binds to the peptidoglycan of all tested Gram-negative species, was harnessed to improve the specific activity of the peptidoglycan hydrolase domain KMV36C. The chimeric peptidoglycan hydrolase (PBD(KZ)-KMV36C) exhibits a threefold higher specific activity than the native catalytic domain (KMV36C). These results demonstrate that the modular assembly of functional domains is a rational approach to improve the specific activity of endolysins from phages infecting Gram-negatives.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19348786     DOI: 10.1016/j.bbrc.2009.03.161

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.

Authors:  Lieh Yoon Low; Chen Yang; Marta Perego; Andrei Osterman; Robert Liddington
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 2.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

Review 3.  Recombinant bacteriophage lysins as antibacterials.

Authors:  Mark Fenton; Paul Ross; Olivia McAuliffe; Jim O'Mahony; Aidan Coffey
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

4.  Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa.

Authors:  Yves Briers; Maarten Walmagh; Barbara Grymonprez; Manfred Biebl; Jean-Paul Pirnay; Valerie Defraine; Jan Michiels; William Cenens; Abram Aertsen; Stefan Miller; Rob Lavigne
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

5.  Structural and functional diversity in Listeria cell wall teichoic acids.

Authors:  Yang Shen; Samy Boulos; Eric Sumrall; Benjamin Gerber; Alicia Julian-Rodero; Marcel R Eugster; Lars Fieseler; Laura Nyström; Marc-Olivier Ebert; Martin J Loessner
Journal:  J Biol Chem       Date:  2017-09-14       Impact factor: 5.157

6.  The zeamine antibiotics affect the integrity of bacterial membranes.

Authors:  Joleen Masschelein; Charlien Clauwers; Karen Stalmans; Koen Nuyts; Wim De Borggraeve; Yves Briers; Abram Aertsen; Chris W Michiels; Rob Lavigne
Journal:  Appl Environ Microbiol       Date:  2014-12-01       Impact factor: 4.792

7.  Expanding the Database of Signal-Anchor-Release Domain Endolysins Through Metagenomics.

Authors:  Marco Túlio Pardini Gontijo; Mateus Pereira Teles; Pedro Marcus Pereira Vidigal; Marcelo Brocchi
Journal:  Probiotics Antimicrob Proteins       Date:  2022-05-07       Impact factor: 4.609

Review 8.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

9.  The secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG.

Authors:  Jhuma Ganguly; Lieh Y Low; Nazia Kamal; Elke Saile; L Scott Forsberg; Gerardo Gutierrez-Sanchez; Alex R Hoffmaster; Robert Liddington; Conrad P Quinn; Russell W Carlson; Elmar L Kannenberg
Journal:  Glycobiology       Date:  2013-03-14       Impact factor: 4.313

Review 10.  Enzybiotics: Enzyme-Based Antibacterials as Therapeutics.

Authors:  Dorien Dams; Yves Briers
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.